Search - tctmd.com

Displaying 321 - 340 of 447

Sort: Relevancy | Date

Presentation TCT 2015

Stem CellBased Ablation for Ventricular Arrhythmias

Presenter: Nabil Dib, Philippe Menasché, Angel Arenal

October 15, 2015

Presentation TCT 2015

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? No Cell Works. Genes are the Answer.

Presenter: Nabil Dib, Philippe Menasché, Marc S. Penn

October 15, 2015

Presentation TCT 2015

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? Cardiac Progenitor Cells Are the Only One!

Presenter: Nabil Dib, Philippe Menasché, Timothy D. Henry

October 15, 2015

Presentation TCT 2015

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? Combination of Cells for Additive Effects: This Is the Key!

Presenter: Nabil Dib, Philippe Menasché, Jay H Traverse

October 15, 2015

Presentation TCT 2015

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? Cardiopoietic Commitment Is the Key!

Presenter: Nabil Dib, Philippe Menasché, Amit Patel

October 15, 2015

Presentation TCT 2015

NuPulse iVAS - A Minimally Invasive Advanced CHF Device

Presenter: Valluvan Jeevanandam, Ulrich P. Jorde

October 14, 2015

Presentation TCT 2015

Debate: Is Transcarotid Artery Revascularization a Revolutionary Advance? No, It Is Too Complex and There Is No Advantage for the Patient!

Presenter: William A. Gray, D. Christopher Metzger, Bernhard Reimers

October 14, 2015

Presentation TCT 2015

Debate: Is Transcarotid Artery Revascularization a Revolutionary Advance? Yes, It Is a Game Changer for Both Outcomes and Adoption of Carotid Stenting!

Presenter: William A. Gray, D. Christopher Metzger, Christopher J. Kwolek

October 14, 2015

Presentation TCT 2015

Advanced Stent Designs and Technologies: What Is Coming to the USA?

Presenter: Larry S. Dean, Simon R. Dixon, David E. Kandzari

October 14, 2015

News Conference News TCT 2015

CREST-2 Triggers Spirited Debate on Merits of CAS vs. CEA

Todd Neale

October 14, 2015

Presentation TCT 2015

Advanced Patient Radiation Management (eg, Follow-up)

Presenter: Stephen Balter, Edwin M. Leidholdt, Jr.

October 13, 2015

News Conference News TCT 2015

Companies With Innovative Technologies Compete in TCT Shark Tank

October 13, 2015

News Conference News TCT 2015

Trial Results Often Struggle to Keep Pace With Evolving Technology

Nicole Lou

October 13, 2015

News Conference News TCT 2015

Debaters Question Need for Further Stent Innovation

Todd Neale

October 13, 2015

News Conference News TCT 2015

Current State of Percutaneous Valve Therapies for Use in Congestive HF Explored

October 13, 2015

Presentation TCT 2015

Advanced iFR: Lesion Assessment Using iFR/FFR Pullback

Presenter: Sergio B Baptista, Eric Van Belle, Justin E. Davies

October 12, 2015

Presentation TCT 2015

Latest Advances in Medical and Device-Based Therapies for Heart Failure

Presenter: Daniel Burkhoff, Ileana L. Pina, JoAnn Lindenfeld

October 12, 2015

News Conference News TCT 2015

Robotic Systems to Play Greater Role in Cath Lab of the Future

Todd Neale

October 12, 2015

News Conference News TCT 2015

Boston Scientific Co-founder John Abele Recognized by TCT Career Achievement Award

October 12, 2015

Presentation TCT 2015

Advanced CLI BTK Intervention: Two Cases From a Master Level Operator

Presenter: J. A. Mustapha, Craig M. Walker, Andrej Schmidt

October 11, 2015

Advertisement

Stem CellBased Ablation for Ventricular Arrhythmias

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? No Cell Works. Genes are the Answer.

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? Cardiac Progenitor Cells Are the Only One!

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? Combination of Cells for Additive Effects: This Is the Key!

In Patients With End-stage Coronary Artery Disease With Ischemia and Scar, Which Cell Type Will Work Best? Cardiopoietic Commitment Is the Key!

NuPulse iVAS - A Minimally Invasive Advanced CHF Device

Debate: Is Transcarotid Artery Revascularization a Revolutionary Advance? No, It Is Too Complex and There Is No Advantage for the Patient!

Debate: Is Transcarotid Artery Revascularization a Revolutionary Advance? Yes, It Is a Game Changer for Both Outcomes and Adoption of Carotid Stenting!

Advanced Stent Designs and Technologies: What Is Coming to the USA?

CREST-2 Triggers Spirited Debate on Merits of CAS vs. CEA

Advanced Patient Radiation Management (eg, Follow-up)

Companies With Innovative Technologies Compete in TCT Shark Tank

Trial Results Often Struggle to Keep Pace With Evolving Technology

Debaters Question Need for Further Stent Innovation

Current State of Percutaneous Valve Therapies for Use in Congestive HF Explored

Advanced iFR: Lesion Assessment Using iFR/FFR Pullback

Latest Advances in Medical and Device-Based Therapies for Heart Failure

Robotic Systems to Play Greater Role in Cath Lab of the Future

Boston Scientific Co-founder John Abele Recognized by TCT Career Achievement Award

Advanced CLI BTK Intervention: Two Cases From a Master Level Operator

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content